BlueCross TEC Critiques Kyphoplasty; Kyphon Trial To Address Concerns
This article was originally published in The Gray Sheet
Executive Summary
Kyphon is conducting a large, multi-center trial in response to concerns about the lack of controls in kyphoplasty trials to date, reflected most recently in a pair of BlueCross BlueShield Association Technology Evaluation Center assessments
You may also be interested in...
MCAC Finds Data Lacking For Vertebroplasty, Kyphoplasty Procedures
Medicare Coverage Advisory Committee panelists generally are confident in outcomes for vertebroplasty and kyphoplasty but find the absence of randomized, controlled clinical data for the procedures troubling
MCAC Finds Data Lacking For Vertebroplasty, Kyphoplasty Procedures
Medicare Coverage Advisory Committee panelists generally are confident in outcomes for vertebroplasty and kyphoplasty but find the absence of randomized, controlled clinical data for the procedures troubling
CMS Considers Creating Guidance On Vertebroplasty, Kyphoplasty Trials
The 1May 24 Medicare Coverage Advisory Committee meeting on vertebral body compression fracture treatments will be the first of several MCAC reviews of spinal procedures, according to CMS